A new study from researchers at the Hebrew University of Jerusalem provides fresh insight into how pancreatic cancer may ...

It's widely known that breastfeeding impacts the health of both mother and child, but the underlying biology that leads to these effects has been understudied.

Discover how innovative start-ups are revolutionising patient care in Singapore, from stroke recovery to early cancer ...

Completed enrollment of Cohort C in the Phase 1 ALLOHA™ trial; patients to be treated with commercial-ready manufacturing process ...

Werewolf Therapeutics, Inc. (Nasdaq: HOWL) (the "Company" or "Werewolf"), an innovative biopharmaceutical company pioneering the development of therapeutics ...

I try not to think of what would have happened if they had found this at the beginning,” says Runkel. “I find that if I just ...

Deep in our cells, a wide range of processes are occurring constantly. These cellular processes rely on enzymes to act as catalysts and set off a series of molecular interactions. There are still many ...

Several health care providers in the Triangle are competing to add medical equipment for cancer detection and treatment.

U.S. FDA Fast Track designation granted to AKY-11891 for the treatment of adult patients with locally advanced or metastatic urothelial cancer who have progressed on or after prior systemic ...

SBIR funding helps medical startups move from research to commercialization. With the program stalled, the pipeline for ...

A new Research Triangle company, Persistence Therapeutics, is developing a small, implantable device that generates and delivers genetically engineered T cells directly inside the body.

The findings were published in the journal Cell. The research was led by Leonie Uhl, Amel Aziba, and Sinah Löbbert, working with colleagues from the University of Würzburg (JMU), Massachusetts ...